MENU

5 Deadly Sins of Specimen Collection and Transport

Card image cap
Nov 09, 2020 · By Lenny
One in five patients receive inaccurate treatment due to a healthcare misdiagnosis, that can originate from the process of collecting to transporting specimen samples. Many samples require specific environmentally controlled handling care for the sample to survive the time it leaves the body to the time the diagnosis is discovered. In the US, there is a complex specimen collection and transport storm brewing because of an antiquated, and many times unmonitored, transport process. It’s hurting patients, while costing healthcare systems millions. 

Here are the top 5 offenders in sample collection and transportation today: 

How is your lab addressing these issues? 

Varied Swabs – Some swabs absorb less organisms and many will not survive transport

Unprotected Bins – While awaiting pickup, samples are subjected to a range of varied ambient  temperatures

Hot Cargo – The sample may degrade further while lab couriers make their rounds

Pressure Exposure – Air transported samples are subjected to high pressures

Dead Samples – Many samples arrive without live organisms

To discuss issues and topics related to this article, click here: https://www.labready.com/#modalLabs

Lenny

Leonard (Lenny) founded Vax-Immune in 2015 with a vision to innovate how we diagnose infectious diseases. As a neonatologist for 40 years, Lenny watched babies die due to misdiagnosis and after realizing that the problem lay in the way samples were being transported, “retired" to develop the first specimen transport system with specimen multiplier technology, eliminating the need for traditional transport and preventing misdiagnosis. The son of Holocaust survivors, Lenny was born in a displaced persons camp in Germany, came to America and went on to graduate from West Point. After completing Airborne, Ranger and Air Defense Artillery schools, he served 24 years in the Army as an academic neonatologist, where he discovered and developed the breakthrough drug for Medimmune, which sold to Astra Zeneca for $15B. After retiring from the Army, Lenny joined the faculty at Baylor College of Medicine where he served as the Chief, Newborn Service, Texas Children’s Hospital, where his vision to build a women’s hospital became the Women’s Pavilion. While at TCH, he spearheaded the birth and care of the world’s first surviving set of octuplets and was featured in The New York Times, CNN, Today Show and in the international media.

By navigating this website, you agree to our Cookie Policy
LabReady | Logo